835 related articles for article (PubMed ID: 19574885)
41. Lipomas of the Oral Cavity: Utility of MDM2 and CDK4 in Avoiding Overdiagnosis as Atypical Lipomatous Tumor.
Stojanov IJ; Mariño-Enriquez A; Bahri N; Jo VY; Woo SB
Head Neck Pathol; 2019 Jun; 13(2):169-176. PubMed ID: 29748845
[TBL] [Abstract][Full Text] [Related]
42. [Dedifferentiated liposarcoma of extremities: a clinicopathologic analysis].
Gong LH; Liu WF; Ding Y; Li L; Zhang M; Sun XQ; Huang XY
Zhonghua Bing Li Xue Za Zhi; 2018 Jul; 47(7):511-516. PubMed ID: 29996315
[No Abstract] [Full Text] [Related]
43. High amplification levels of MDM2 and CDK4 correlate with poor outcome in patients with dedifferentiated liposarcoma: A cytogenomic microarray analysis of 47 cases.
Ricciotti RW; Baraff AJ; Jour G; Kyriss M; Wu Y; Liu Y; Li SC; Hoch B; Liu YJ
Cancer Genet; 2017 Dec; 218-219():69-80. PubMed ID: 29153098
[TBL] [Abstract][Full Text] [Related]
44. Clinical and biological significance of CDK4 amplification in well-differentiated and dedifferentiated liposarcomas.
Italiano A; Bianchini L; Gjernes E; Keslair F; Ranchere-Vince D; Dumollard JM; Haudebourg J; Leroux A; Mainguené C; Terrier P; Chibon F; Coindre JM; Pedeutour F
Clin Cancer Res; 2009 Sep; 15(18):5696-703. PubMed ID: 19737942
[TBL] [Abstract][Full Text] [Related]
45. Dedifferentiated liposarcoma composed predominantly of rhabdoid/epithelioid cells: a frequently misdiagnosed highly aggressive variant.
Agaimy A; Michal M; Hadravsky L; Michal M
Hum Pathol; 2018 Jul; 77():20-27. PubMed ID: 29307627
[TBL] [Abstract][Full Text] [Related]
46. Diagnostic Utility Of Fish For MDM2 In Adipocytic Neoplasms.
Sarwar S; Mushtaq S; Hassan U; Maqbool H; Qazi R
J Ayub Med Coll Abbottabad; 2021; 33(4):563-567. PubMed ID: 35124908
[TBL] [Abstract][Full Text] [Related]
47. Detection of MDM2 gene amplification or protein expression distinguishes sclerosing mesenteritis and retroperitoneal fibrosis from inflammatory well-differentiated liposarcoma.
Weaver J; Goldblum JR; Turner S; Tubbs RR; Wang WL; Lazar AJ; Rubin BP
Mod Pathol; 2009 Jan; 22(1):66-70. PubMed ID: 18836421
[TBL] [Abstract][Full Text] [Related]
48. GLI1 Coamplification in Well-Differentiated/Dedifferentiated Liposarcomas: Clinicopathologic and Molecular Analysis of 92 Cases.
Sharma AE; Dickson M; Singer S; Hameed MR; Agaram NP
Mod Pathol; 2024 Jun; 37(6):100494. PubMed ID: 38621503
[TBL] [Abstract][Full Text] [Related]
49. Amplification of FRS2 in atypical lipomatous tumour/well-differentiated liposarcoma and de-differentiated liposarcoma: a clinicopathological and genetic study of 146 cases.
Jing W; Lan T; Chen H; Zhang Z; Chen M; Peng R; He X; Zhang H
Histopathology; 2018 Jun; 72(7):1145-1155. PubMed ID: 29368794
[TBL] [Abstract][Full Text] [Related]
50. High level of CDK4 amplification is a poor prognostic factor in well-differentiated and dedifferentiated liposarcoma.
Lee SE; Kim YJ; Kwon MJ; Choi DI; Lee J; Cho J; Seo SW; Kim SJ; Shin YK; Choi YL
Histol Histopathol; 2014 Jan; 29(1):127-38. PubMed ID: 23852861
[TBL] [Abstract][Full Text] [Related]
51. Negative MDM2/CDK4 immunoreactivity does not fully exclude MDM2/CDK4 amplification in a subset of atypical lipomatous tumor/ well differentiated liposarcoma.
Machado I; Vargas AC; Maclean F; Llombart-Bosch A
Pathol Res Pract; 2022 Apr; 232():153839. PubMed ID: 35303521
[TBL] [Abstract][Full Text] [Related]
52. Primary retroperitoneal myxoid/round cell liposarcoma is a nonexisting disease: an immunohistochemical and molecular biological analysis.
de Vreeze RS; de Jong D; Tielen IH; Ruijter HJ; Nederlof PM; Haas RL; van Coevorden F
Mod Pathol; 2009 Feb; 22(2):223-31. PubMed ID: 18820664
[TBL] [Abstract][Full Text] [Related]
53. Liposarcoma masquerading as an inflammatory pseudotumor: a case report.
Reagh JJ; Eckstein RP; Selinger CI; Evans J; O'Toole SA; Gill AJ
J Med Case Rep; 2016 Mar; 10():64. PubMed ID: 26987706
[TBL] [Abstract][Full Text] [Related]
54. Expanding the differential of cutaneous epithelioid tumors: A case of dedifferentiated liposarcoma with epithelioid features involving the skin, with review of the literature.
Chambers M; Badin DJ; Sriharan AA; Linos KD
J Cutan Pathol; 2020 Jun; 47(6):554-560. PubMed ID: 31995237
[TBL] [Abstract][Full Text] [Related]
55. Atypical Spindle Cell Lipomatous Tumor: Clinicopathologic Characterization of 232 Cases Demonstrating a Morphologic Spectrum.
Mariño-Enriquez A; Nascimento AF; Ligon AH; Liang C; Fletcher CD
Am J Surg Pathol; 2017 Feb; 41(2):234-244. PubMed ID: 27879515
[TBL] [Abstract][Full Text] [Related]
56. Liposarcomas in young patients: a study of 82 cases occurring in patients younger than 22 years of age.
Alaggio R; Coffin CM; Weiss SW; Bridge JA; Issakov J; Oliveira AM; Folpe AL
Am J Surg Pathol; 2009 May; 33(5):645-58. PubMed ID: 19194281
[TBL] [Abstract][Full Text] [Related]
57. CD10 (neprilysin) expression: a potential adjunct in the distinction of hibernoma from morphologic mimics.
Gjorgova-Gjeorgjievski S; Fritchie K; Folpe AL
Hum Pathol; 2021 Apr; 110():12-19. PubMed ID: 33406387
[TBL] [Abstract][Full Text] [Related]
58. MDM2 copy numbers in well-differentiated and dedifferentiated liposarcoma: characterizing progression to high-grade tumors.
Ware PL; Snow AN; Gvalani M; Pettenati MJ; Qasem SA
Am J Clin Pathol; 2014 Mar; 141(3):334-41. PubMed ID: 24515760
[TBL] [Abstract][Full Text] [Related]
59. Lipophyllodes of the breast. A reappraisal of fat-rich tumors of the breast based on 22 cases integrated by immunohistochemical study, molecular pathology insights, and clinical follow-up.
Bacchi CE; Wludarski SC; Lamovec J; Ben Dor D; Ober E; Salviato T; Zanconati F; De Maglio G; Pizzolitto S; Sioletic S; Falconieri G
Ann Diagn Pathol; 2016 Apr; 21():1-6. PubMed ID: 27040923
[TBL] [Abstract][Full Text] [Related]
60. Atypical lipomatous tumor/"well-differentiated liposarcoma" of the skin clinically presenting as a skin tag: clinicopathologic, immunohistochemical, and molecular analysis of 2 cases.
Paredes BE; Mentzel T
Am J Dermatopathol; 2011 Aug; 33(6):603-7. PubMed ID: 21358383
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
